John Gill's Net Worth
$15.7 Million
Who is John Gill?
John Gill has an estimated net worth of $15.7 Million. This is based on reported shares across multiple companies, which include Altimmune, Inc., and TETRALOGIC PHARMACEUTICALS Corp.
SEC CIK
John Gill's CIK is 0001409939
Past Insider Trading and Trends
2016 was John Gill's most active year for acquiring shares with 8 total transactions. John Gill's most active month to acquire stocks was the month of August. 2016 was John Gill's most active year for disposing of shares, totalling 7 transactions. John Gill's most active month to dispose stocks was the month of August. 2016 saw John Gill paying a total of $639,300.00 for 310,000 shares, this is the most they've acquired in one year. In 2020 John Gill cashed out on 25,275 shares for a total of $100,426.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altimmune, Inc. (ALT) Snapshot price: $10.355
President and CEOJohn Gill owns 722,244 units of Common Stock, par value $0.0001 per share which is worth $7,478,836.62, 822,244 units of Common Stock, $0.0001 par value per share which is worth $8,514,336.62 and 2,771 units of Common Stock, par value $0.0001 which is worth $28,693.71. From 2007 to 2023 John Gill acquired a total of 840,094 shares in Altimmune, Inc. at a cost of $423,643.50, John also disposed a total of 11,139 shares of Altimmune, Inc. equalling to $141,136.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
| -49.48% | -2.71K |
$15.00 | -$40,710.00 | 2.77K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 4
| -42.93% | -8.43K |
$11.92 | -$100,426.00 | 11.2K |
Scheduled
|
Nov 30
| ||
Form 4
| +607.43% | 16.85K |
—
|
—
| 19.62K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
| +1.22% | 1K |
$4.34 | $4,343.50 | 83.22K |
Jun 2
| |||
Form 4
| +13.85% | 100K |
$2.20 | $220,000.00 | 822.24K |
Nov 22
| |||
Form 4
| +17.97% | 110K |
$1.81 | $199,300.00 | 722.24K |
Sep 15 - Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 612.24K |
—
|
—
| 612.24K |
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRALOGIC PHARMACEUTICALS Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||